References and Notes
1a
Adronov A.
Fréchet JMJ.
Chem. Commun.
2000,
1701
1b
Gilat SL.
Adronov A.
Fréchet JMJ.
Angew. Chem. Int. Ed.
1999,
38:
1422
2a
Kleij AW.
Gossage RA.
Gebbink RJMK.
Brinkmann N.
Reijerse EJ.
Kragl U.
Lutz M.
Speck AL.
van Koten G.
J.
Am. Chem. Soc.
2000,
122:
12112
2b
Mager M.
Becke S.
Windisch H.
Denninger U.
Angew. Chem. Int. Ed.
2001,
40:
1898
3
Kleiji AW.
Gossage RA.
Gebbink RJMK.
Brinkmann N.
Reijerse E.
Vögtle F.
Vicinelli V.
Ceroni P.
Maestri M.
Balzani V.
Angew.
Chem. Int. Ed.
2002,
41:
3595
4a
Rajakumar P.
Ganesan K.
Jayavelu S.
Murugesan K.
Synth.
Lett.
2005,
7:
1121
4b
Gillies ER.
Fréchet JMJ.
J.
Am. Chem. Soc.
2002,
124:
14137
4c
Patri AK.
Majoros IJ.
Baker JR.
Curr. Opin. Chem. Biol.
2002,
6:
466
4d
Padilla De Jesus OL.
Ihre HR.
Gagne L.
Fréchet JMJ.
Szoka FC.
Bioconjugate
Chem.
2002,
13:
453
5a
Wang Q.
Chan TR.
Hilgraf R.
Fokin VV.
Sharpless KB.
Finn MG.
J. Am. Chem. Soc.
2003,
125:
3192
5b
Burley GA.
Gierlich J.
Mofid MR.
Nir H.
Tal S.
Eichen Y.
Carell T.
J. Am. Chem. Soc.
2006,
128:
1398
6a
Kukowska-Latallo JF.
Candido KA.
Cao Z.
Nigavekar SS.
Majoros IJ.
Thomas TP.
Balogh LP.
Khan MK.
Baker JR.
Cancer Res.
2005,
65:
5317
6b
Fuchs S.
Otto H.
Jehle S.
Henklein P.
Schlüter
AD.
Chem.
Commun.
2005,
1830
6c
Majoros IJ.
Myc A.
Thomas T.
Mehta CB.
Baker JR.
Biomacromolecules
2006,
7:
572
7a
Cloninger MJ.
Curr. Opin. Chem.
Biol.
2002,
6:
742
7b
Boas U.
Heegaard PMH.
Chem.
Soc. Rev.
2004,
33:
43
7c
Shaunak S.
Thomas S.
Gianasi E.
Godwin A.
Jones E.
Teo I.
Mireskandari K.
Luthert P.
Duncan R.
Patterson S.
Khaw P.
Brocchini S.
Nat. Biotechnol.
2004,
22:
977
7d
McCarthy TD.
Karellas P.
Henderson SA.
Giannis M.
O’Keefe DF.
Heery G.
Paull JRA.
Matthews BR.
Holan G.
Mol. Pharm.
2005,
2:
312
7e
Lee CC.
MacKay JA.
Fréchet JMJ.
Szoka FC.
Nat.
Biotechnol.
2005,
23:
1517
8a
Zhang Q.
Ning Z.
Yan Y.
Qian S.
Tian H.
Macromol.
Rapid Commun.
2008,
29:
193
8b
Zhang Q.
Ning Z.
Tian H.
Dyes
Pigments
2009,
81:
80
9
Lee YC.
Lee RT.
Acc. Chem. Res.
1995,
28:
321
10
Tornoe CM.
Christensen C.
Meldal MJ.
J.
Org. Chem.
2002,
67:
3057
11
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless
KB.
Angew.
Chem. Int. Ed.
2002,
41:
2596
12
Deguise I.
Lagnoux D.
Roy R.
New
J. Chem.
2007,
31:
1321
13
Chabre YM.
Contino-Pepin C.
Placide V.
Shiao TC.
Roy R.
J.
Org. Chem.
2008,
73:
5602
14
Rajakumar P.
Ganesan K.
Tetrahedron: Asymmetry
2005,
16:
2295
15a
Maikoch M.
Schleicher K.
Drockenmuller E.
Hawker CJ.
Russell T.
Wu P.
Forkin VV.
Macromolecules
2005,
38:
3663
15b
Fernandez-Megia E.
Correa J.
Riguera R.
Biomacromolecules
2006,
7:
3104
16a
Mourer M.
Hapiot F.
Tilloy S.
Monflier E.
Menuel S.
Eur. J. Org. Chem.
2008,
5723
16b
Coogan MP.
Robert L.
Jenkins A.
Nutz E.
J. Organomet.
Chem.
2004,
689:
694
17
General Procedure
for the Cu-Catalyzed Huisgen ‘Click Reaction’:
Acetylenic derivative (1.0 mmol) was mixed with acetylated carbohydrate
azide (2.1 mmol, 2.1 equiv) in t-BuOH
and H2O mixture (1:1, 8 mL) solution. Sodium ascorbate
(0.4 mmol, 0.4 equiv) was added as a solid, followed by the addition
of CuSO4 (0.2 mmol, 0.2 equiv). The reaction was stirred
overnight at r.t. The solvent was evaporated under reduced pressure
and the crude product was dissolved in EtOAc (100 mL), washed with
NH4Cl solution (50 mL), brine solution (50 mL) and H2O
(50 mL) and then dried over Na2SO4 and concentrated
on a rotary evaporator. The residue was purified by column chromatog-raphy
(SiO2) with hexane-EtOAc as eluent to give the corresponding
triazole compound.
18
General Procedure
for the Conversion of Dendritic Chlorides to Azides: Dendritic
chloride (1.0 mmol) was dissolved in acetone and H2O
(4:1, 8 mL). NaN3 (1.5 mmol, 1.5 equiv) was added, and
the mixture was heated at 60 ˚C for 3 h. The reaction mixture
was cooled to r.t., acetone was evaporated and the reaction mixture
was diluted with H2O (100 mL), and extracted with EtOAc
(2 × 100 mL). The organic layer was washed with sat. NaCl
(50 mL), dried over Na2SO4, and evaporated
to give the dendritic azide.
19
First-Generation
Dendritic Azide 11: white solid; yield: 99%; R
f
0.6
(EtOAc-hexane, 1:1); mp 133 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 1.78, 1.96,
2.00 (3 × s, 24 H), 3.92-3.97 (m, 2 H), 4.04-4.11
(m, 2 H), 4.21-4.26 (m, 4 H), 5.13 (s, 4 H), 5.18-5.21
(m, 2 H), 5.32-5.43 (m, 4 H), 5.84 (d, J = 2.7 Hz,
2 H), 6.50 (d, J = 2.1 Hz, 2
H), 6.57 (d, J = 2.1 Hz, 1 H), 7.86
(s, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 19.1,
19.5, 19.5, 19.6, 53.6, 60.6, 60.9, 66.8, 69.4, 71.7, 74.2, 84.8, 100.6,
106.8, 120.3, 137.0, 143.6, 158.6, 167.9, 168.4, 168.9, 169.5. MS (FAB): m/z = 987 [M+].
Anal. Calcd for C41H49N9O20:
C, 49.85; H, 5.00; N, 12.76. Found: C, 49.81; H, 4.96; N, 12.51.
20
Second-Generation
Dendritic Azide 13: white solid; yield: 99%; R
f
0.72
(EtOAc-hexane, 7:3); mp 159 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 1.82, 2.02,
2.05, 2.07 (4 × s, 48 H), 4.02-4.05 (m, 4 H),
4.11-4.17 (m, 4 H), 4.24 (d, J = 4.8
Hz, 2 H), 4.27-4.32 (m, 4 H), 5.14 (s, 8 H), 5.17 (s, 4
H), 5.27 (t, J = 9.6 Hz, 4 H),
5.39-5.50 (m, 12 H), 5.93 (d, J = 8.7
Hz, 4 H), 6.51 (s, 4 H), 6.59 (s, 2 H), 6.60 (s, 1 H), 6.64 (s,
2 H), 7.63 (s, 2 H), 7.96 (s, 4 H). ¹³C
NMR (75 MHz, CDCl3): δ = 20.1, 20.5,
20.5, 20.6, 54.0, 54.6, 61.6, 61.8, 62.1, 67.7, 70.4, 72.6, 75.1,
85.8, 101.7, 107.9,107.7, 107.8, 121.6, 123.0, 137.0, 144.2, 144.3,
159.4, 159.7, 168.9, 169.4, 169.9, 170.5. MS (FAB): m/z = 2217 [M+].
Anal. Calcd for C95H109N21O42:
C, 51.46; H, 4.95; N, 13.27. Found: C, 51.41; H, 4.90; N, 13.14.
21
General Procedure
for the De-O-acetylation (Zemplen Reaction): Acetylated dendrimers
(1.0 mmol) was dissolved in a mixture of anhyd MeOH-anhyd
THF-anhyd CH2Cl2 (16 mL, 6:1:1) and
to this mixture was added a solution of sodium methoxide (1 M MeOH)
until pH 9-10 was reached. The reaction was stirred at
r.t. for 48 h. At the end, H2O was added for entire solubilization
of desired compound and the solution was neutralized by addition
of ion-exchange resin (Amberlite IR 120 H+)
until pH 6-7 was attained. The solution was filtered and
the solvent was removed in vacuo with rotary evaporator. The residue
was then lyophilized to yield the fully deprotected glycodenrimer
in a ca. 99% yield.
22
Glycodendrimer
2: white solid; yield: 95%; [α]D
²5 +44.5
(c = 1, DMSO). IR (KBr): 3404,
1372, 1230, 1042, 826 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 3.21 (d, J = 8.4 Hz, 4 H), 3.55-3.66
(m, 8 H), 5.18 (q, J = 3.6 Hz,
4 H), 5.43 (d, J = 9.0 Hz, 2
H), 6.88 (d, J = 8.4 Hz, 2 H),
7.22 (t, J = 7.4 Hz, 2 H), 7.33
(t, J = 7.5 Hz, 2 H), 7.75-7.78
(m, 4 H), 7.94 (d, J = 9.0 Hz,
2 H), 8.06 (d, J = 9.0 Hz, 2
H). ¹³C NMR (75 MHz, CDCl3): δ = 60.4,
62.2, 72.0, 76.4, 79.4, 87.2, 115.8, 119.3, 123.0, 123.9, 124.4,
126.5, 128.9, 129.5, 133.2, 143.2, 143.2, 153.4. MS (FAB): m/z = 772 [M+].
Anal. Calcd for C38H40N6O12:
C, 59.06; H, 5.22; N, 10.88. Found: C, 59.03; H, 5.20; N, 10.87.
23
Glycodendrimer
4: white solid; yield: 92%; [α]D
²5 +15.5
(c = 1, DMSO). IR (KBr): 3426,
1595, 1412, 1046, 834 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 3.00 (s,
8 H), 3.43-3.56 (m, 8 H), 4.85-4.94 (m, 12 H),
5.14 (s, 8 H), 5.31 (d, J = 9.0
Hz, 4 H), 5.54 (s, 4 H), 6.26 (s, 4 H), 6.53 (s, 2 H), 6.60 (d, J = 8.4 Hz, 2 H), 7.90 (t, J = 7.5 Hz, 2 H), 7.04 (t, J = 7.5 Hz, 2 H), 7.34 (s, 2
H), 7.45 (d, J = 9.0 Hz, 2 H),
7.65 (d, J = 9.0 Hz, 2 H), 7.76
(d, J = 9.0 Hz, 2 H), 8.20 (s,
4 H). ¹³C NMR (75 MHz, CDCl3): δ = 52.7,
60.5, 60.8, 62.3, 69.2, 72.0, 76.6, 79.4, 87.4, 100.8, 107.1, 115.8,
119.3, 123.8, 124.0, 124.3, 126.3, 128.0, 128.9, 129.4, 133.1, 137.7,
142.4, 143.5, 153.2, 159.3. MS (MALDI-TOF): m/z = 1665 [M+]. Anal.
Calcd for C76H84N18O26:
C, 54.80; H, 5.08; N, 15.14. Found: C, 54.79; H, 5.08; N, 15.11.
24
Glycodendrimer
6: white solid; yield: 92%; [α]D
²5 +2.2
(c = 1, DMSO). IR (KBr): 3390,
1598, 1461, 1384, 1168, 1047, 828 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 3.24 (s,
16 H), 3.68-3.82 (m, 16 H), 5.07 (s, 8 H), 5.11 (s, 16
H), 5.18 (d, J = 4.8 Hz, 8 H),
5.32 (d, J = 3.6 Hz, 12 H),
5.44 (d, J = 9.0 Hz, 8 H), 5.54
(s, 8 H), 5.57 (s, 4 H), 6.45 (s, 4 H), 6.62 (s, 8 H), 6.71 (s,
2 H), 6.77 (s, 4 H), 6.81 (d, J = 8.4
Hz, 2 H), 7.10 (t, J = 7.8 Hz,
2 H), 7.24 (t, J = 6.6 Hz, 2
H), 7.52 (s, 2 H), 7.66 (d, J = 8.7
Hz, 2 H), 7.83 (d, J = 7.5 Hz,
2 H), 7.96 (d, J = 8.4 Hz, 2
H), 8.29 (s, 4 H), 8.32 (s, 8 H). ¹³C
NMR (75 MHz, CDCl3): δ = 52.8, 60.5,
60.8, 62.2, 69.2, 72.0, 76.6, 79.4, 87.3, 100.9, 107.1, 115.7, 119.3,
123.8, 124.0, 124.3, 124.8, 125.7, 126.3, 127.8, 127.9, 128.8, 129.2, 129.3,
133.0, 137.6, 138.0, 142.4, 142.7, 143.5, 153.2, 159.1, 159.2. MS
(MALDI-TOF): m/z = 3451 [M+].
Anal. Calcd for C152H172N42O54:
C, 52.90; H, 5.02; N, 17.05. Found: C, 52.89; H, 5.02; N, 17.02.